Barclays’s Sight Sciences SGHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$73.6K Sell
19,522
-45,728
-70% -$247K ﹤0.01% 4156
2025
Q4
$517K Buy
65,250
+6,094
+10% +$38.9K ﹤0.01% 3823
2025
Q3
$203K Sell
59,156
-13,734
-19% -$51.1K ﹤0.01% 4281
2025
Q2
$301K Buy
72,890
+34,245
+89% +$114K ﹤0.01% 4050
2025
Q1
$92.7K Sell
38,645
-17,649
-31% -$49.7K ﹤0.01% 4433
2024
Q4
$205K Buy
56,294
+5,994
+12% +$27.3K ﹤0.01% 4295
2024
Q3
$317K Buy
50,300
+38,248
+317% +$257K ﹤0.01% 4051
2024
Q2
$80.4K Sell
12,052
-3,187
-21% -$18.8K ﹤0.01% 4016
2024
Q1
$80.5K Sell
15,239
-14,486
-49% -$68.1K ﹤0.01% 4507
2023
Q4
$153K Buy
29,725
+20,081
+208% +$62K ﹤0.01% 4523
2023
Q3
$32.5K Hold
9,644
﹤0.01% 4031
2023
Q2
$79.9K Sell
9,644
-1,415
-13% -$12.7K ﹤0.01% 3645
2023
Q1
$96.7K Buy
11,059
+5,209
+89% +$57.8K ﹤0.01% 4202
2022
Q4
$71.4K Buy
5,850
+4,937
+541% +$46.9K ﹤0.01% 4408
2022
Q3
$6K Sell
913
-168
-16% -$1.42K ﹤0.01% 4471
2022
Q2
$10K Sell
1,081
-3,457
-76% -$30.4K ﹤0.01% 4634
2022
Q1
$53K Buy
+4,538
New +$69.8K ﹤0.01% 4099

Other funds holding SGHT

Barclays's SGHT Position: Q1 2026 in Review

Barclays reduced its Sight Sciences (SGHT) stake by 70% in Q1 2026, selling an estimated $247K and leaving 19,522 shares worth $73.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4156.

Barclays first reported a position in SGHT in Q1 2022 and has held it in 17 quarters since. The position peaked at $517K in Q4 2025. 114 funds tracked by Wall St. Rank hold SGHT as of Q1 2026.

  • Barclays held 19,522 shares of Sight Sciences worth $73.6K as of Q1 2026.
  • Barclays sold 45,728 Sight Sciences shares in Q1 2026, an estimated $247K.
  • Sight Sciences made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4156 holding.
  • Barclays first reported a position in Sight Sciences in Q1 2022 and has held it in 17 quarters since.
  • Barclays's Sight Sciences position peaked at $517K in Q4 2025.
  • 114 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.